Luxturna: FDA documents reveal the value of a costly gene therapy

Title
Luxturna: FDA documents reveal the value of a costly gene therapy
Authors
Keywords
-
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-02-01
DOI
10.1016/j.drudis.2019.01.019

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started